Nebulized hypertonic saline 3% for 1 versus 3 days in hospitalized bronchiolitis: a blinded non-inferiority randomized controlled trial

Nebulized hypertonic saline 3% for 1 versus 3 days in hospitalized bronchiolitis: a blinded non-inferiority randomized controlled trial

Abstract Background The use and optimal duration of treatment with nebulized hypertonic saline (HS) in infants hospitalized for acute bronchiolitis is unclear. The objective was to compare the efficacy of 1 versus 3 days of nebulized 3% HS at 72 h of treatment. We conducted a blinded non-inferiority...

Full description

Bibliographic Details
Main Authors: Gaëlle Beal, Catherine Barbier, Sophie Thoret, Amandine Rubio, Mathilde Bonnet, Roseline Mazet, Anne Ego, Isabelle Pin
Format: Article
Language:English
Published: BMC 2019-11-01
Series:BMC Pediatrics
Subjects:
Bronchiolitis
Hypertonic saline
Children
Online Access:http://link.springer.com/article/10.1186/s12887-019-1804-0

Internet

http://link.springer.com/article/10.1186/s12887-019-1804-0

Similar Items